Clinical Trial Update: HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating HRS-4642 in combination with other antitumor therapies for locally advanced or metastatic pancreatic cancer is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• HRS-4642

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Locally Advanced or Metastatic Pancreatic Cancer With | Phase 1, Phase 2 | Status: RECRUITING